Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder

ClinicalTrials.gov ID: NCT05749055

Public ClinicalTrials.gov record NCT05749055. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 3:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The ENCALM Trial: A Randomized, Double-blind, Placebo-controlled Monotherapy Trial to Evaluate the Efficacy and Safety of ENX-102 in Patients With Generalized Anxiety Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD)

Study identification

NCT ID
NCT05749055
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Engrail Therapeutics INC
Industry
Enrollment
252 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2, 2023
Primary completion
Sep 17, 2025
Completion
Sep 17, 2025
Last update posted
Sep 24, 2025

2023 – 2025

United States locations

U.S. sites
32
U.S. states
14
U.S. cities
32
Facility City State ZIP Site status
IMA Clinical Research Phoenix Phoenix Arizona 85012
Collaborative Neuroscience Research, LLC (CNS) Garden Grove California 92845
Sun Valley Research Center Imperial California 92251
Alliance Research Long Beach California 90712
NRC Research Institute Los Angeles California 90015
Excell Research, Inc. Oceanside California 92056
Anderson Clinical Research Redlands California 92374
California Neuroscience Research, LLC Sherman Oaks California 91403
Pacific Clinical Research Management Group Upland California 91786
Sunwise Clinical Research Walnut Creek California 94596
Mountain View Clinical Research Denver Colorado 80209
Vertex Clinical Research Clermont Florida 34711
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256
Accel Research Sites Network - Lakeland CRU Lakeland Florida 33803
Accel Research Sites Network - Maitland CRU Maitland Florida 32751
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801
CenExel iResearch, LLC Savannah Georgia 31405
Collective Medical Research Overland Park Kansas 66210
Boston Clinical Trials Boston Massachusetts 02131
Precise Research Centres Flowood Mississippi 39232
IMA Clinical Research Las Vegas Nevada 89102
SPRI Clinical Trials, LLC Brooklyn New York 11235
Neurobehavioral Research Cedarhurst New York 11516
Richmond Behavioral Associates Staten Island New York 10314
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119
Austin Clinical Trials Partners Austin Texas 78737
FutureSearch Trials of Dallas Dallas Texas 75231
Baylor College of Medicine Houston Texas 77030
Aim Trials Plano Texas 75093
Grayline Research Center Wichita Falls Texas 76309
Alpine Research Organization Clinton Utah 84015
Core Clinical Research Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05749055, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2025 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05749055 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →